[go: up one dir, main page]

SI1629844T1 - Sistem podaljšanega oddajanja s kontrolirano začetno dozo - Google Patents

Sistem podaljšanega oddajanja s kontrolirano začetno dozo

Info

Publication number
SI1629844T1
SI1629844T1 SI200430465T SI200430465T SI1629844T1 SI 1629844 T1 SI1629844 T1 SI 1629844T1 SI 200430465 T SI200430465 T SI 200430465T SI 200430465 T SI200430465 T SI 200430465T SI 1629844 T1 SI1629844 T1 SI 1629844T1
Authority
SI
Slovenia
Prior art keywords
delivery system
initial burst
core
controlled initial
longterm
Prior art date
Application number
SI200430465T
Other languages
English (en)
Inventor
Teppo Riihimaki
Original Assignee
Bayer Schering Pharma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34932022&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1629844(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Oy filed Critical Bayer Schering Pharma Oy
Publication of SI1629844T1 publication Critical patent/SI1629844T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Communication Control (AREA)
  • Materials For Medical Uses (AREA)
  • Vending Machines For Individual Products (AREA)
  • Adjustment And Processing Of Grains (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Selective Calling Equipment (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
SI200430465T 2004-07-13 2004-07-13 Sistem podaljšanega oddajanja s kontrolirano začetno dozo SI1629844T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04396049A EP1629844B2 (en) 2004-07-13 2004-07-13 A longterm delivery system with controlled initial burst

Publications (1)

Publication Number Publication Date
SI1629844T1 true SI1629844T1 (sl) 2007-12-31

Family

ID=34932022

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430465T SI1629844T1 (sl) 2004-07-13 2004-07-13 Sistem podaljšanega oddajanja s kontrolirano začetno dozo

Country Status (24)

Country Link
US (1) US7850986B2 (sl)
EP (1) EP1629844B2 (sl)
JP (1) JP4881861B2 (sl)
KR (1) KR20070035032A (sl)
CN (1) CN1984639A (sl)
AT (1) ATE372772T1 (sl)
AU (1) AU2005261682B2 (sl)
BR (1) BRPI0513295A (sl)
CA (1) CA2569542C (sl)
DE (1) DE602004008912T3 (sl)
DK (1) DK1629844T4 (sl)
ES (1) ES2293193T5 (sl)
HK (1) HK1086751A1 (sl)
IL (1) IL179846A (sl)
MX (1) MX2007000433A (sl)
NO (1) NO334931B1 (sl)
NZ (1) NZ551823A (sl)
PL (1) PL1629844T5 (sl)
PT (1) PT1629844E (sl)
RU (1) RU2412693C2 (sl)
SI (1) SI1629844T1 (sl)
UA (1) UA91337C2 (sl)
WO (1) WO2006005794A1 (sl)
ZA (1) ZA200610473B (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1629844T1 (sl) 2004-07-13 2007-12-31 Bayer Schering Pharma Oy Sistem podaljšanega oddajanja s kontrolirano začetno dozo
WO2006078320A2 (en) * 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US8124601B2 (en) * 2007-11-21 2012-02-28 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
BR112014001450A2 (pt) * 2011-07-20 2017-07-18 F Kiser Patrick dispositivos intravaginais para distribuição de droga
RU2669395C2 (ru) * 2012-01-18 2018-10-11 Волдвайд Инновейтив Хелскэа, Инк. Изменяемая окклюзивная повязка
AR089765A1 (es) 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN105310974B (zh) * 2014-08-01 2019-08-23 山东绿叶制药有限公司 罗替戈汀及其衍生物或其药用盐的植入剂

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832252A (en) 1970-09-29 1974-08-27 T Higuchi Method of making a drug-delivery device
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
ATE86484T1 (de) 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
RU2088166C1 (ru) 1993-08-10 1997-08-27 Педдер Валерий Викторович Способ контрацепции и устройство для его осуществления
BR9507313A (pt) 1994-04-08 1997-10-07 Atrix Lab Inc Composição liquida de liberação adequada para a formação de um implante de liberação controlada sistema polimérico curativo filmico microporoso biodegradável precursor de implante de liberação controlada para a implantação em um indivíduo polímero termoplástico solvente orgánico composicão de pré-polimero liquido componente de liberação controlada agente ativo uso da composição liquida de liberação e processos para forma um implante microporoso de liberação prolongada e para liberar um agente ativo em um individuo
US5492947A (en) * 1994-06-23 1996-02-20 Aspen Research Corporation Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative
GB2290964A (en) 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
FI97947C (fi) 1994-09-27 1997-03-25 Leiras Oy Menetelmä lääkepreparaatin valmistamiseksi
GB9522403D0 (en) † 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
WO1999061062A1 (en) † 1998-05-29 1999-12-02 Massachusetts Institute Of Technology Cyclodextrin complexes
AU6517900A (en) 1999-08-03 2001-02-19 Smith & Nephew, Inc. Controlled release implantable devices
ES2283394T3 (es) * 2000-01-11 2007-11-01 Bertex Pharma Gmbh Kit para implantacion que contiene una fase de soporte y un disolvente.
US6299894B1 (en) 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
AU2002210580A1 (en) 2000-10-20 2002-04-29 Leiras Oy Drug delivery system
NZ528377A (en) 2001-03-27 2005-05-27 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of an antimicrobial agent
CN1210079C (zh) 2001-04-25 2005-07-13 上海市计划生育科学研究所 阴道环制剂及其应用
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
US8404272B2 (en) 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
CN1822815B (zh) † 2003-07-10 2012-04-11 沃纳奇尔科特(爱尔兰)有限公司 阴道内药物传递装置
CN100531800C (zh) * 2004-03-24 2009-08-26 奥尔加侬股份有限公司 基于聚乙烯乙酸乙烯酯共聚物的药物递送系统
SI1629844T1 (sl) 2004-07-13 2007-12-31 Bayer Schering Pharma Oy Sistem podaljšanega oddajanja s kontrolirano začetno dozo

Also Published As

Publication number Publication date
RU2006145900A (ru) 2008-06-27
DE602004008912D1 (de) 2007-10-25
IL179846A0 (en) 2007-05-15
AU2005261682B2 (en) 2010-02-11
ATE372772T1 (de) 2007-09-15
WO2006005794A1 (en) 2006-01-19
NO20070805L (no) 2007-02-12
JP2008506672A (ja) 2008-03-06
EP1629844A1 (en) 2006-03-01
NO334931B1 (no) 2014-07-14
DE602004008912T3 (de) 2012-09-13
DE602004008912T2 (de) 2008-06-05
DK1629844T4 (da) 2012-05-29
US7850986B2 (en) 2010-12-14
HK1086751A1 (en) 2006-09-29
IL179846A (en) 2012-07-31
KR20070035032A (ko) 2007-03-29
CN1984639A (zh) 2007-06-20
AU2005261682A1 (en) 2006-01-19
CA2569542C (en) 2012-10-09
MX2007000433A (es) 2007-03-07
ZA200610473B (en) 2008-06-25
PL1629844T5 (pl) 2012-10-31
EP1629844B2 (en) 2012-04-18
RU2412693C2 (ru) 2011-02-27
JP4881861B2 (ja) 2012-02-22
NZ551823A (en) 2008-07-31
CA2569542A1 (en) 2006-01-19
PL1629844T3 (pl) 2008-02-29
EP1629844B1 (en) 2007-09-12
BRPI0513295A (pt) 2008-05-06
PT1629844E (pt) 2007-10-17
ES2293193T5 (es) 2012-06-13
UA91337C2 (ru) 2010-07-26
ES2293193T3 (es) 2008-03-16
DK1629844T3 (da) 2007-10-15
US20080031922A1 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
HK1086751A1 (en) A longterm delivery system with controlled initialburst
GB0705434D0 (en) Control systems and methods for active controlled bottomhole pressure systems
AU2002224777A1 (en) Device for controlling, regulating and/or putting an active implant into operation
PL1709365T3 (pl) System oraz sposób stabilizacji i sterowania płomieniem
EP1733513A4 (en) METHOD AND SYSTEM FOR CONTROLLING THE EXCHANGE OF MESSAGES RELATING TO VEHICLES
DE50200579D1 (de) Kraftstoffsystem, verfahren zum betreiben des kraftstoff-systems, computerprogramm sowie steuer- und/oder regelgerät zur steuerung des kraftstoffsystems
WO2007146049A3 (en) Morphology profiles for control of agent release rates from polymer matrices
AU2003237402A1 (en) Fluid delivery system with closed-loop flow control and method
DE60040173D1 (de) Präsenz- und sitzungsbehandlungsinformationen
WO2006078320A3 (en) Methods for manufacturing delivery devices and devices thereof
ZA200802280B (en) System and method for controlling pilot injection
WO2008060560A3 (en) Game table television and projector system, and method for same
WO2001052833A8 (en) Compositions for delivery of a cortisol antagonist
WO2007089715A3 (en) Method for treatment of neuropathic pain
AU3683501A (en) Foam control composition and method for controlling foam in aqueous systems
TW200631496A (en) One step fire ant control
HK1049823A1 (en) Controlling method, controller and system for mobile body
EP2037663A4 (en) PROCESS, SYSTEM AND DEVICE FOR SAVING AND PLAYING POC MEETINGS
WO2008005686A8 (en) Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye
HK1083962A1 (en) Call device, call control system, call management system, and call control method
MY122838A (en) Treating allergic and inflammatory conditions
PL1819214T3 (pl) Szklarnia, układ sterowania klimatem szklarni oraz sposób sterowania klimatem szklarni
GB0515171D0 (en) System and method for open-loop or closed-loop control of the operating processes in a vehicle
FR2894562B1 (fr) Dispositif de fourniture d'oxygene a des occupants d'un aeronef et organe de regulation de pression pour un tel dispositif
SG120999A1 (en) Automatic gain control system and method